drugset / Trial / NCT01693549

Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes

NCT01693549

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether cabazitaxel is effective in the treatment of metastatic breast cancer.

Timeline

Start
2012-09
Primary completion
2017-07-10
Completion
2017-07-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Cabazitaxel Other / unclassified 25 mg/m2 Intravenous

Indications